0001478242-19-000023.txt : 20190327 0001478242-19-000023.hdr.sgml : 20190327 20190327170205 ACCESSION NUMBER: 0001478242-19-000023 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190327 DATE AS OF CHANGE: 20190327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BOUSBIB ARI CENTRAL INDEX KEY: 0001184180 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35907 FILM NUMBER: 19708981 MAIL ADDRESS: STREET 1: UNITED TECHNOLOGIES CORP STREET 2: ONE FINANCIAL PLAZA CITY: HARTFORD STATE: CT ZIP: 06101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IQVIA HOLDINGS INC. CENTRAL INDEX KEY: 0001478242 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 271341991 STATE OF INCORPORATION: NC FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-998-2000 MAIL ADDRESS: STREET 1: 4820 EMPEROR BLVD. CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles IMS Holdings, Inc. DATE OF NAME CHANGE: 20161003 FORMER COMPANY: FORMER CONFORMED NAME: Quintiles Transnational Holdings Inc. DATE OF NAME CHANGE: 20091208 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-03-25 0001478242 IQVIA HOLDINGS INC. IQV 0001184180 BOUSBIB ARI C/O IQVIA HOLDINGS INC. 83 WOOSTER HEIGHTS ROAD DANBURY CT 06810 1 1 0 0 See Remarks Common Stock 2019-03-25 4 A 0 96000 21.36 A 826137 D Common Stock 2019-03-25 4 S 0 96000 140.96 D 730137 D Common Stock 543302 I By Trust Employee Stock Option (Right to Buy) 21.36 2019-03-25 4 X 0 96000 0 D 2015-09-01 2020-12-01 Common Stock 96000 0 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 14, 2018. The price reported in Column 4 is a weighted average price for shares sold in multiple transactions. The sale prices range from $139.99 to $141.59 per share. The reporting person has provided to the issuer, and undertakes to provide to the Commission staff or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Shares held in Orohena Trust. Remarks: Chairman, Chief Executive Officer & President /s/ Matthew Gilmartin, Attorney-in-Fact for Ari Bousbib 2019-03-27